These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 7268190)
1. Reversible metabolism and pharmacokinetics: application to prednisone-prednisolone. Wagner JG; DiSanto AR; Gillespie WR; Albert KS Res Commun Chem Pathol Pharmacol; 1981 Jun; 32(3):387-405. PubMed ID: 7268190 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and pharmacodynamics of three different prednisolone prodrugs: effect on circulating lymphocyte subsets and function. Frey BM; Walker C; Frey FJ; de Weck AL J Immunol; 1984 Nov; 133(5):2479-87. PubMed ID: 6237151 [TBL] [Abstract][Full Text] [Related]
3. [Pharmacokinetic parameters of prednisone and prednisolone in healthy volunteers]. Etienne SD; Vandermeersch V; Chosidow O; Vu-Thi-My-Le C; Godeau P; Diquet B; Herson S Ann Med Interne (Paris); 1990; 141(6):507-11. PubMed ID: 2285202 [TBL] [Abstract][Full Text] [Related]
4. Effect on nephrotic syndrome on absorption and disposition of prednisolone in children. Rocci ML; Assael BM; Appiani AC; Edefonti A; Jusko WJ Int J Pediatr Nephrol; 1982 Sep; 3(3):159-66. PubMed ID: 7141787 [TBL] [Abstract][Full Text] [Related]
5. Effects of thyroid dysfunction on prednisolone and prednisone interconversion and disposition in the rat. Murata R; Haughey DB; Jusko WJ Drug Metab Dispos; 1990; 18(4):403-8. PubMed ID: 1976060 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of prednisone and prednisolone at steady state in the rabbit. Unadkat JD; Rowland M Drug Metab Dispos; 1985; 13(4):503-9. PubMed ID: 2863117 [TBL] [Abstract][Full Text] [Related]
7. Bioavailability and reversible metabolism of prednisone and prednisolone in man. Garg V; Jusko WJ Biopharm Drug Dispos; 1994 Mar; 15(2):163-72. PubMed ID: 8011967 [TBL] [Abstract][Full Text] [Related]
8. Dose dependent pharmacokinetics of prednisone and prednisolone in man. Rose JQ; Yurchak AM; Jusko WJ J Pharmacokinet Biopharm; 1981 Aug; 9(4):389-417. PubMed ID: 7310640 [TBL] [Abstract][Full Text] [Related]
9. The non-linear pharmacokinetics of prednisone and prednisolone. I. Theoretical. Ferry JJ; Wagner JG Biopharm Drug Dispos; 1986; 7(1):91-101. PubMed ID: 3955201 [TBL] [Abstract][Full Text] [Related]
10. Prednisone for chronic active liver disease: pharmacokinetics, including conversion to prednisolone. Schalm SW; Summerskill WH; Go VL Gastroenterology; 1977 May; 72(5 Pt 1):910-3. PubMed ID: 849821 [TBL] [Abstract][Full Text] [Related]
11. Tissue distribution of prednisolone in the rabbit. Khalafallah N; Jusko WJ J Pharmacol Exp Ther; 1984 Jun; 229(3):719-25. PubMed ID: 6726655 [TBL] [Abstract][Full Text] [Related]
12. [Pharmacokinetics and pharmacodynamics of prednisolone following extremely high dosage as prednisolone hemisuccinate]. Rohdewald VP; Rehder J; Möllmann H; Barth J; Derendorf H Arzneimittelforschung; 1987 Feb; 37(2):194-8. PubMed ID: 3580023 [TBL] [Abstract][Full Text] [Related]
13. Non-compartmental analysis of pharmacokinetic data after multiple intravenous and oral administration. Rohatagi S; Kan S; Derendorf H Pharmazie; 1997 Jul; 52(7):529-32. PubMed ID: 9266589 [TBL] [Abstract][Full Text] [Related]
14. Longitudinal assessment of everolimus in de novo renal transplant recipients over the first post-transplant year: pharmacokinetics, exposure-response relationships, and influence on cyclosporine. Kovarik JM; Kahan BD; Kaplan B; Lorber M; Winkler M; Rouilly M; Gerbeau C; Cambon N; Boger R; Rordorf C; Clin Pharmacol Ther; 2001 Jan; 69(1):48-56. PubMed ID: 11180038 [TBL] [Abstract][Full Text] [Related]
15. Prednisolone clearance at steady state in dogs. Frey FJ; Frey BM; Greither A; Benet LZ J Pharmacol Exp Ther; 1980 Nov; 215(2):287-91. PubMed ID: 7441495 [TBL] [Abstract][Full Text] [Related]
16. A single dose of azathioprine does not affect the pharmacokinetics of prednisolone following oral prednisone. Frey FJ; Lozada F; Guentert T; Frey BM Eur J Clin Pharmacol; 1981 Feb; 19(3):209-12. PubMed ID: 7215419 [TBL] [Abstract][Full Text] [Related]
17. Kinetics and interconversion of prednisolone and prednisone studied with new radioimmunogassays. Meikle AW; Weed JA; Tyler FH J Clin Endocrinol Metab; 1975 Oct; 41(4):717-21. PubMed ID: 1176582 [TBL] [Abstract][Full Text] [Related]
18. Effect of liquid diet on serum protein binding and prednisolone concentrations after oral prednisone. Uribe M; Schalm SW; Summerskill WH; Go VL Gastroenterology; 1976 Aug; 71(2):362-4. PubMed ID: 939399 [TBL] [Abstract][Full Text] [Related]
19. Influence of cholestyramine on the pharmacokinetics of rosiglitazone and its metabolite, desmethylrosiglitazone, after oral and intravenous dosing of rosiglitazone: impact on oral bioavailability, absorption, and metabolic disposition in rats. Muzeeb S; Venkatesh P; Mullangi R; Srinivas NR Xenobiotica; 2006 Sep; 36(9):838-56. PubMed ID: 16971347 [TBL] [Abstract][Full Text] [Related]
20. Studies comparing the metabolic clearance rate of 11 beta,17,21-trihydroxypregn-1,4-diene-3,20-dione (prednisolone) after oral 17,21-dihydroxypregn-1,4-diene-3,11,20-trione and intravenous prednisolone. Hsueh WA; Paz-Guevara A; Bledsoe T J Clin Endocrinol Metab; 1979 May; 48(5):748-52. PubMed ID: 429520 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]